Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
14
Mins
28 May 2019
Review of the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2019
Profs Dominique Valla and Tom Hemming Karlsen welcomed the approximately 9,000 delegates from 125 countries, with the former offering some sound advice…
1
Mins
28 May 2019
The Role of Adipose Tissue in Metabolic and Cardiovascular Complications After Liver Transplantation
Metabolic and cardiovascular complications are an important burden in patients after liver transplantation (LT) for many reasons, including as a result…
5
Mins
28 May 2019
ILC 2019 Interview: Professor Dina Tiniakos
We met with EMJ Hepatology Editorial Board member, Prof Dina Tiniakos, at the ILC, to discuss her career path and her experience at the congress…
18
Mins
28 May 2019
Editor's Pick: Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease
This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…
1
Mins
28 May 2019
Efficacy of Oral Thrombopoietin Receptor Agonist Lusutrombopag in Chronic Liver Disease by Underlying Disease Aetiology
Among patients with chronic liver disease (CLD), thrombocytopenia (TCP) is a frequent complication.1,2 Before invasive procedures and surgery in CLD…
6
Mins
28 May 2019
Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…
7
Mins
28 May 2019
Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy
The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…
2
Mins
28 May 2019
A Comparison of Currently Available Direct-Acting Antiviral Hepatitis C Virus Therapy in Canada: On the Path to Elimination
As many as 250,000 Canadians are living with hepatitis C virus (HCV) infection,1 and specific populations, such as people who use drugs (PWUD)…
2
Mins
28 May 2019
The NIACE Score: A Prognostic Indicator in Hepatocellular Carcinoma
The NIACE score is an easy-to-calculate prognostic score, and this study demonstrated that NIACE can distinguish between two subgroups with different…
9
Mins
28 May 2019
Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis
The autoimmune liver diseases (AILD) have been categorised classically as either autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC)…
←
1
2
3
…
704
705
706
707
708
709
710
…
1,048
1,049
1,050
→